Join
Live feed
·
INSIDERFilingvia Quantisnow
Arbutus Biopharma Corporation logo

SEC Form 4: Mcelhaugh Michael J. was granted 83,700 shares, increasing direct ownership by 6% to 1,391,157 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABUS (Arbutus Biopharma Corporation) and more on Quantisnow.